Company logo

AVRO - AVROBIO, Inc.

NASDAQ -> Healthcare -> Biotechnology
Cambridge, United States
Type: Equity

AVRO price evolution
AVRO
(in millions $) 30 Sep 2023 30 Jun 2023 1 May 2023 31 Jan 2023
Current assets
Cash $106.13 $124.97 $72.33 $92.85
Short term investments
Net receivables $0.27 $0.27 $0.27
Inventory
Total current assets $109.17 $128.84 $77.25 $99.96
Long term investments $0.4 $0.4 $0.28
Property, plant & equipment $0.91 $4.55 $5.43 $3.95
Goodwill & intangible assets
Total noncurrent assets $1.35 $4.99 $5.75 $3.99
Total investments $0.4 $0.4 $0.28
Total assets $110.52 $133.84 $83 $103.95
Current liabilities
Accounts payable $0.91 $1.07 $0.59 $0.38
Deferred revenue
Short long term debt $1.65 $2.25 $2.63 $1
Total current liabilities $7.56 $11.66 $14.3 $13.12
Long term debt $0.1 $0.13 $15.71 $15.28
Total noncurrent liabilities $0.1 $0.13 $15.71 $15.46
Total debt $1.75 $2.38 $18.34 $16.46
Total liabilities $7.66 $11.8 $30.01 $28.58
Shareholders' equity
Retained earnings -$468.49 -$446.91 -$514.39 -$489.43
Other shareholder equity $75.37
Total shareholder equity $102.86 $122.04 $53 $75.37
(in millions $) 31 Jan 2023 31 Dec 2021 31 Dec 2020 31 Dec 2019
Current assets
Cash $92.85 $190.06 $260.17 $187.04
Short term investments
Net receivables $0.27 $2.7 $2.6 $1.9
Inventory
Total current assets $99.96 $199.15 $267.24 $195.7
Long term investments
Property, plant & equipment $3.95 $4.13 $3.06 $3.7
Goodwill & intangible assets
Total noncurrent assets $3.99 $4.69 $3.99 $4.81
Total investments
Total assets $103.95 $203.84 $271.23 $200.51
Current liabilities
Accounts payable $0.38 $3.49 $2.68 $3.95
Deferred revenue
Short long term debt $1
Total current liabilities $13.12 $19.39 $16.61 $14.02
Long term debt $15.28 $14.95
Total noncurrent liabilities $15.46 $14.97 $0.28 $0.48
Total debt $16.46 $14.95
Total liabilities $28.58 $34.36 $16.89 $14.5
Shareholders' equity
Retained earnings -$489.43 -$383.54 -$264.42 -$144.7
Other shareholder equity $75.37 $169.48
Total shareholder equity $75.37 $169.48 $254.34 $186.01
(in millions $) 30 Sep 2023 30 Jun 2023 1 May 2023 31 Dec 2022
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development $14.83 $11.15 $18.14
Selling, general & administrative $6.26 $4.58 $7.12
Total operating expenses $22.93 -$68.01 $25.26
Operating income -$22.93 $68.01 -$25.26
Income from continuing operations
EBIT -$22.98 $67.97 -$25.28
Income tax expense
Interest expense -$1.41 $0.49 -$0.24
Net income
Net income -$21.58 $67.48 -$25.03
Income (for common shares) -$21.58 $67.48 -$25.03
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Revenue
Total revenue
Cost of revenue
Gross Profit
Operating activities
Research & development $72.19 $83.11 $87.24 $54.97
Selling, general & administrative $33.25 $35.73 $32.99 $20.84
Total operating expenses $105.43 $118.84 $120.23 $75.81
Operating income -$105.43 -$118.84 -$120.23 -$75.81
Income from continuing operations
EBIT -$105.59 -$119.35 -$119.71 -$72.97
Income tax expense
Interest expense $0.3 -$0.22
Net income
Net income -$105.89 -$119.13 -$119.71 -$72.97
Income (for common shares) -$105.89 -$119.13 -$119.71 -$72.97
(in millions $) 30 Sep 2023 30 Jun 2023 31 Mar 2023 31 Dec 2022
Net income -$21.58 $67.48 -$24.96 -$25.03
Operating activities
Depreciation $0.41 $0.88 $0.92 $3.06
Business acquisitions & disposals
Stock-based compensation $2.22 $1.53 $2.53 $2.25
Total cash flows from operations -$20.22 -$14.65 -$20.28 -$23.67
Investing activities
Capital expenditures $1.2 -$0.01
Investments
Total cash flows from investing $1.2 $83.74 -$0.01
Financing activities
Dividends paid
Sale and purchase of stock $0.18 $0.03 $0.06 $0.06
Net borrowings -$16.35
Total cash flows from financing $0.18 -$16.32 $0.06 $0.06
Effect of exchange rate
Change in cash and equivalents -$18.85 $52.76 -$20.24 -$23.61
(in millions $) 31 Dec 2022 31 Dec 2021 31 Dec 2020 31 Dec 2019
Net income -$105.89 -$119.13 -$119.71 -$72.97
Operating activities
Depreciation $4.17 $1.4 $1.21 $0.85
Business acquisitions & disposals
Stock-based compensation $11.52 $18.58 $15.63 $6.8
Total cash flows from operations -$97.21 -$98.03 -$98.8 -$67.67
Investing activities
Capital expenditures -$0.27 -$2.46 -$1.18 -$1.58
Investments
Total cash flows from investing -$0.27 -$2.46 -$1.18 -$1.58
Financing activities
Dividends paid
Sale and purchase of stock $0.26 $15.47 $172.62 $129.99
Net borrowings $14.9
Total cash flows from financing $0.26 $30.37 $172.62 $129.99
Effect of exchange rate
Change in cash and equivalents -$97.21 -$70.11 $72.64 $60.74
Fundamentals
Market cap $59.32M
Enterprise value -$45.05M
Shares outstanding 44.60M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio 0.58
Book/Share 2.31
Cash/Share 2.38
EPS N/A
ROA N/A
ROE N/A
Debt/Equity 0.38
Net debt/EBITDA N/A
Current ratio 14.44
Quick ratio 14.44